Low Awareness of and Preference for Event-Driven PrEP Among US MSM

January 27-28 and February 3-4, 2021
Across 2 independent surveys of US MSM, 10% to 18% of participants indicated a preference for on-demand vs daily PrEP dosing yet only 1% to 3% of current PrEP recipients were using on-demand dosing.
Format: Microsoft PowerPoint (.ppt)
File Size: 184 KB
Released: February 9, 2021

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@clinicaloptions.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Educational grant provided by:
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
Merck Sharp & Dohme Corp.
ViiV Healthcare

Related Content

Concise Clinical Care Options (CCO) presentation by Darrell H. S. Tan, MD, FRCPC, PhD, on approved and guideline-recommended oral HIV PrEP regimens

person default Darrell H. S. Tan, MD, FRCPC, PhD Physicians: maximum of 0.5 AMA PRA Category 1 Credits Released: July 29, 2021 Expired: July 28, 2022

REACH study: adherence to dapivirine vaginal ring and oral PrEP among African females 16-21 years, in Clinical Care Options (CCO) report from IAS 2021

Released: July 24, 2021

GEMS: ART resistance, adherence in persons with HIV on PrEP in Sub-Saharan Africa, reported by Clinical Care Options (CCO) from IAS 2021

Released: July 24, 2021

Dr Adeeba Kamarulzaman previews 11th IAS Conference on HIV Science, with official coverage and analysis from Clinical Care Options (CCO)

Adeeba Kamarulzaman, MBBS, FRACP, FASc Released: July 19, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue